Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway

被引:126
|
作者
Sharma, S.
Chopra, K.
Kulkarni, S. K.
Agrewala, J. N.
机构
[1] Inst Microbial Technol, Immunol Lab, Chandigarh 160036, India
[2] Panjab Univ, Div Pharmacol, Univ Inst Pharmaceut Sci, Chandigarh 160014, India
来源
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2007年 / 147卷 / 01期
关键词
CD28; CD40; CD80; CTLA-4; curcumin; IL-10; resveratrol;
D O I
10.1111/j.1365-2249.2006.03257.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The role of resveratrol and curcumin is well documented in cancer, inflammation, diabetes and various other diseases. However, their immunosuppressive action on T cells, B cells and macrophages is not well documented. In the present study, we have ascertained the effect of resveratrol and curcumin on T and B cells and macrophages. The most striking findings were that both resveratrol and curcumin suppressed the activity of T and B cells and macrophages, as evidenced by significant inhibition in proliferation, antibody production and lymphokine secretion. Interestingly, curcumin imparted immunosuppression by mainly down-regulating the expression of CD28 and CD80 and up-regulating CTLA-4. Resveratrol also functioned by decreasing the expression of CD28 and CD80, as well as by augmenting the production of interleukin (IL)-10.
引用
收藏
页码:155 / 163
页数:9
相关论文
共 50 条
  • [1] Increased production of circulating soluble co-stimulatory molecules CTLA-4, CD28 and CD80 in patients with rheumatoid arthritis
    Cao, Ju
    Zou, Lin
    Luo, Peixin
    Chen, Pu
    Zhang, Liping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2012, 14 (04) : 585 - 592
  • [2] Is the Genetic Background of Co-Stimulatory CD28/CTLA-4 Pathway the Risk Factor for Prostate Cancer?
    Karabon, Lidia
    Tupikowski, K.
    Tomkiewicz, A.
    Partyka, A.
    Pawlak-Adamska, E.
    Wojciechowski, A.
    Kolodziej, A.
    Dembowski, J.
    Zdrojowy, R.
    Frydecka, I.
    PATHOLOGY & ONCOLOGY RESEARCH, 2017, 23 (04) : 837 - 843
  • [3] CD28/CTLA-4 and CD80/CD86 familiesSignaling and function
    Jacqueline M. Slavik
    Jill E. Hutchcroft
    Barbara E. Bierer
    Immunologic Research, 1999, 19 : 1 - 24
  • [4] CD28/CTLA-4 and CD80/CD86 families - Signaling and function
    Slavik, JM
    Hutchcroft, JE
    Bierer, BE
    IMMUNOLOGIC RESEARCH, 1999, 19 (01) : 1 - 24
  • [5] Co-stimulatory blockade of the CD28/CD80-86/CTLA-4 balance in transplantation: impact on memory T cells?
    Ville, Simon
    Poirier, Nicolas
    Blancho, Gilles
    Vanhove, Bernard
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [6] Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cells
    Lazetic, S
    Leong, SR
    Chang, JCC
    Ong, R
    Dawes, G
    Punnonen, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (41) : 38660 - 38668
  • [7] Aberrant production of soluble co-stimulatory molecules CTLA-4 and CD28 in patients with chronic hepatitis B
    Cao, Ju
    Zhang, Liping
    Huang, Shifeng
    Chen, Pu
    Zou, Lin
    Chen, Hui
    Xiang, Yu
    Lai, Xiaofei
    Ren, Guosheng
    MICROBIAL PATHOGENESIS, 2011, 51 (04) : 262 - 267
  • [8] Interactions of CD80 and CD86 with CD28 and CTLA4
    Ellis, JH
    Burden, MN
    Vinogradov, DV
    Linge, C
    Crowe, JS
    JOURNAL OF IMMUNOLOGY, 1996, 156 (08): : 2700 - 2709
  • [9] A Transendocytosis Perspective on the CD28/CTLA-4 Pathway
    Soskic, Blagoje
    Qureshi, Omar S.
    Hou, Tiezheng
    Sansom, David M.
    ADVANCES IN IMMUNOLOGY, VOL 124, 2014, 124 : 95 - +
  • [10] PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways
    Zhao, Yunlong
    Lee, Calvin K.
    Lin, Chia-Hao
    Gassen, Rodrigo B.
    Xu, Xiaozheng
    Huang, Zhe
    Xiao, Changchun
    Bonorino, Cristina
    Lu, Li-Fan
    Bui, Jack D.
    Hui, Enfu
    IMMUNITY, 2019, 51 (06) : 1059 - +